Accelerate Diagnostics Files for Chapter 11 Protection
Accelerate Diagnostics has filed for Chapter 11 bankruptcy and plans to sell its assets through a court-supervised process.
Read MorePosted by Chris Wolski | May 9, 2025 | Company News |
Accelerate Diagnostics has filed for Chapter 11 bankruptcy and plans to sell its assets through a court-supervised process.
Read MorePosted by Chris Wolski | May 1, 2025 | Lab Safety |
Thermo Fisher has launched the 1500 Series Class II, Type A2 Biological Safety Cabinet, enhancing lab safety and operational efficiency.
Read MorePosted by Chris Wolski | Apr 30, 2025 | Prostate |
Fellow Health showcased innovative research, emphasizing mail-in semen testing to enhance prostate cancer diagnostics and PVSA care.
Read MorePosted by Chris Wolski | Apr 30, 2025 | Unknown Origin & Other Cancer Types |
Mursla Bio has received FDA Breakthrough Device Designation for EvoLiver, a novel blood test using Dynamic Biopsy technology.
Read MorePosted by Chris Wolski | Apr 25, 2025 | Labwear & Consumables |
AnalytiChem has launched Redipor as a global, ready-to-use culture media brand to serve critical microbiological applications.
Read More